Consider referring any patient with chronic pain to a psychologist or therapist to address the psychological effects of chronic pain.
A team-based approach, adequate consultative support, and training can begin to address some of these barriers. Patients may have individual barriers to accessing care or participating in self-management. Provide them with specific support as needed.
“It helps you feel better,” says Dr. Solanki. “It’s another great thing to do to distract yourself when you have an urge to smoke. Exercising is an incredibly good antidote to smoking.”
Psychiatric comorbidities. Review the past medical history and assess the presence of psychiatric conditions that could affect the patient’s response to chronic pain, communications with the patient about chronic pain, or treatment.
Urine drug testing is important for verifying the patient is actually using the prescribed medication, and is not selling it or providing it to others (called “diversion”). Urine drug testing also helps with patient safety, by assuring through testing that other sedating substances or medications are not in use.
Early refills. The patient demonstrates a pattern of requesting early refills (3 or more) or escalating drug use in the absence of an acute change in his or her medical condition.
Advise patients to store naloxone in a location where it can be easily found and accessed by the patient and others in an emergency. Store naloxone in a stable temperature environment in a highly visible and easy to access location.
A variety of psychosocial factors, including patient vulnerability and resilience, influence the development and experience of chronic pain, and affect outcomes such as pain persistence and disability.
Social, personal, and family risks. Being an opioid user carries a risk for social stigma. Additional risks are inherent to possessing opioids, including becoming a target for home invasion. Insecure storage may put other family members and pets at risk for opioid poisoning.
Monitor for respiratory depression in the first 72 hours after initiating or increasing the opioid dose.
Opioid tolerant patients. Morphine is the default choice, unless contraindicated. Morphine can be prescribed by all routes, unlike oxycodone. It has a straightforward dose calculation with a predictable analgesic interchange and conversion between parenteral and oral dosing.
When attempting to taper down opioid dosing for a patient with complex persistent dependence, aberrant behaviors and fluctuation in opioid use can occur. The development of protracted abstinence syndrome may lead to worsening pain, declining function, and worsening psychiatric symptoms. Paradoxically, the same symptoms may occur with maintenance of long-term high dose opioid therapy. Pain relief is more complex than analgesia measured by pain scales. Pain relief involves relief in the affective component of the pain experience, get more info as mediated through mesolimbic reward and learning pathways involving the endogenous opioid system.
They reduce cravings and withdrawal, making quitting easier. Have a healthcare professional find the best NRT for you. Additionally, prescription medications like bupropion and varenicline can reduce cravings and ease the process. Consult your doctor to explore the best options for you.
Treatment. In the treatment plan, address both the underlying cause and the associated acute pain. In developing a treatment plan for the acute pain, consider the degree of tissue trauma, the patient’s situation, and any unique patient factors.